Alzamend Neuro, Inc. (ALZN)
NASDAQ: ALZN · Real-Time Price · USD
1.700
+0.063 (3.85%)
At close: Sep 2, 2026, 4:00 PM EDT
1.680
-0.020 (-1.15%)
After-hours: Sep 2, 2026, 7:30 PM EDT

Alzamend Neuro Ratios and Metrics

Millions USD. Fiscal year is May - Apr.

Total Valuation

Fiscal Quarter
CurrentQ4 2026Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022
Period Ending
Sep '26 Apr '26 Jan '26 Oct '25 Jul '25 Apr '25 Jan '25 Oct '24 Jul '24 Apr '24 Jan '24 Oct '23 Jul '23 Apr '23 Jan '23 Oct '22 Jul '22 Apr '22 Jan '22 Oct '21 Jul '21
848107467356114453641128595136186377
Market Cap Growth (YoY)
6.32%-0.56%32.55%36.89%117.00%-10.66%8.59%-37.90%-93.16%-90.80%-91.13%-89.87%-48.27%-44.08%-52.92%-39.92%-77.51%----
Enterprise Value
72443126355103946551007183123171376
Last Close Price
1.641.142.152.532.255.9410.2214.1332.1363.9977.40157.57611.55738.85895.991579.501200.281377.002065.502889.005973.75

Price Ratios

Fiscal Quarter
CurrentQ4 2026Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022
Period Ending
Sep '26 Apr '26 Jan '26 Oct '25 Jul '25 Apr '25 Jan '25 Oct '24 Jul '24 Apr '24 Jan '24 Oct '23 Jul '23 Apr '23 Jan '23 Oct '22 Jul '22 Apr '22 Jan '22 Oct '21 Jul '21
PB Ratio
9.505.923.742.201.221.101.791.87-2.48-1.88-1.50-4.22-389.0217.4210.9212.717.597.1111.3614.2824.60
P/TBV Ratio
10.625.923.742.201.221.101.791.87-----17.4210.9212.717.597.1111.3614.2824.60

Financial Efficiency

Fiscal Quarter
CurrentQ4 2026Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022
Period Ending
Sep '26 Apr '26 Jan '26 Oct '25 Jul '25 Apr '25 Jan '25 Oct '24 Jul '24 Apr '24 Jan '24 Oct '23 Jul '23 Apr '23 Jan '23 Oct '22 Jul '22 Apr '22 Jan '22 Oct '21 Jul '21
Debt / Equity Ratio
----------0.12---------0.030.03
Net Debt / Equity Ratio
-0.97-0.97-1.24-1.02-1.05-0.99-0.97-1.090.990.030.080.0815.02-1.69-1.26-1.04-1.03-1.05-0.99-1.02-0.99
Net Debt / EBITDA Ratio
0.080.080.390.770.910.890.810.710.160.010.020.010.110.35---1.14---
Net Debt / FCF Ratio
0.090.090.440.760.700.570.450.510.200.010.030.020.170.580.881.101.442.091.872.484.08
Quick Ratio
0.530.531.466.205.726.224.633.260.410.120.070.060.621.792.795.6111.2212.0725.259.2110.61
Current Ratio
1.311.311.996.586.036.585.443.800.490.140.160.210.882.033.196.3111.7812.3726.629.8311.41
Return on Equity (ROE)
-373.18%-373.18%-249.97%-144.76%-302.25%-657.17%--1092.96%--4408.31%-1196.26%-496.81%-277.69%-181.47%-173.29%-115.43%-98.61%-160.92%-182.81%--74.84%
Return on Assets (ROA)
-163.99%-163.99%-107.01%-72.71%-97.46%-107.38%-106.08%-121.64%-214.47%-189.73%-166.84%-166.06%-129.40%-90.97%-92.20%-63.04%-56.19%-88.35%-91.33%--
Return on Capital Employed (ROCE)
-1195.70%-1195.70%-322.00%-134.30%-116.70%-113.30%-122.00%-155.40%608.30%383.10%407.10%565.00%13607.80%-488.30%-263.50%-143.10%-116.70%-92.30%-80.80%-63.20%-38.70%

Yields

Fiscal Quarter
CurrentQ4 2026Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022
Period Ending
Sep '26 Apr '26 Jan '26 Oct '25 Jul '25 Apr '25 Jan '25 Oct '24 Jul '24 Apr '24 Jan '24 Oct '23 Jul '23 Apr '23 Jan '23 Oct '22 Jul '22 Apr '22 Jan '22 Oct '21 Jul '21
Earnings Yield
-112.67%-202.25%-86.16%-61.16%-95.80%-103.51%-68.55%-83.26%-246.21%-203.75%-218.40%-134.03%-35.00%-28.04%-24.13%-11.27%-15.41%-13.03%-7.17%-4.46%-1.60%
FCF Yield
-103.62%-186.01%-75.48%-60.89%-124.06%-157.47%-119.95%-113.92%-203.70%-172.40%-162.47%-79.55%-22.39%-16.82%-13.06%-7.46%-9.46%-7.08%-4.64%-2.87%-0.99%
Buyback Yield / Dilution
-640.27%-640.27%-765.27%-985.74%-1121.34%-499.67%-293.71%-118.23%-8.09%-4.07%-4.79%-4.52%-5.89%-9.45%-11.38%-16.34%-21.90%-22.64%-18.56%-12.05%-5.79%
SEC Filings: 10-K · 10-Q